echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > How can pharmaceutical companies go further after the epidemic?

    How can pharmaceutical companies go further after the epidemic?

    • Last Update: 2020-02-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Together with hope, embrace warmth, no spring, no dream When spring returns to the earth, all things will be renewed and smoke will die No winter is insurmountable, no spring will not come Disasters are always sudden, but at this time we should unite as one We believe that everything will pass and spring will bloom This pneumonia is equivalent to a sudden brake on the whole Chinese society Over the years, various media have been reflecting that China is moving too fast We need to stop our fast pace and wait for our soul We thought we had enough experience and reserve after SARS, but after the experience of this pneumonia, the country realized that there was still too much lacking Especially in basic medical equipment and drug research and development, it is not enough to make things stable What the public feels the most is that the products directly related to epidemic prevention, such as masks, disinfectants and pneumonia treatment drugs, are in short supply due to the sharp rise in demand The medical and health industry is the first line in the anti epidemic war After the outbreak, what changes will the health care industry make? First of all, this anti epidemic campaign is a health education for the public People's needs for masks, electronic thermometers, air disinfectors, and multiple cycle electronic masks will become the daily needs of the public Taking masks as an example, the data shows that the production capacity of masks in China is up to 20 million per day, and the daily production capacity of professional N95 masks is only 600000 But it corresponds to hundreds of millions of demands Even after the outbreak, there is still a huge demand for masks, because more and more people will wear masks in public in the future Taking Japan, a "big country of masks", as an example, data shows that the annual output of Japan in 2018 is about 5.5 billion, including nearly 4.3 billion household masks In Japan, masks are endowed with more functions besides medical use Such as anti pollen, spray, and face masks In addition, more technology is also used for masks The epidemic is the "catalyst" of internet medical treatment, and the online free diagnosis fire Before 2019, the proportion of online consultation was only 2% - 4% Under the catalysis of the epidemic, the proportion of online consultation has increased to about 10% During the outbreak, online free clinic services were launched on platforms such as Dingxiang doctor, micro doctor and Ali health Internet medical has the advantages of remote, professional, convenient and efficient On Taobao, as long as you click the "buy medicine and don't go out" service, after online consultation, there will be online doctors to prescribe and deliver the medicine directly to your home In addition, in June 2019, the state clearly stipulated that Internet health care can be included in medical insurance payment There are sufficient reasons to judge: in the future, internet medical platform enterprises will usher in a big outbreak In the pharmaceutical purchase process, some conventional medicines can be purchased through platforms such as hungry medicine and Jingdang fast medicine This is also an explosive opportunity for pharmaceutical e-commerce Under the influence of the epidemic, in addition to anxiety and depression, the general public is also prone to similar emotions Many psychological platforms also dropped out of antidepressant diagnosis and lectures The depression Institute is one of them This platform helps patients with depression to provide complete solutions, including the channel docking of medical treatment and consultation, as well as disease education and derivative services to solve insomnia and anxiety problems in the patient community Ren kezeng, CEO of depression research institute, said, "this cognitive education of social science will change the gluing state of big market and small demand, and the psychological track is pregnant with value power in the growing period." During the Spring Festival, the Institute of depression launched a series of initiatives In the future, more and more online services such as psychological counseling are coming Wuhan is the disaster area of the epidemic There are many problems such as the shortage of hospital beds and medical staff The epidemic revealed that the supply of medical services in China is insufficient, and the quality and efficiency of the public health system need to be improved According to the data of the National Bureau of statistics, as of 2018, the total number of licensed doctors in China is 3010400, with an average of 21.5 "licensed doctors per 10000 people" According to who statistics, the United States has 26 people, Japan has 24, and European countries have more than 30 In other words, even if we do not consider the short-term surge in demand caused by the new coronavirus epidemic, the supply of medical services in China is still relatively insufficient In addition, the number of the elderly population will continue to increase in the next two decades, and the demand for medical services will continue to rise, so the demand for doctors will be greater The outbreak of novel coronavirus pneumonia has a broader and urgent need to solve problems in the short board of medical and public health in China Novel coronavirus was the most exciting news during the epidemic In February 4th, Li Lanjuan, a member of the China Academy of engineering and the National Health Protection Committee's high-level expert group, announced two effective drugs for treating pneumonia caused by new coronavirus, namely Abe Dore and Da Lou Bernard Vee, and the United States' anti viral drug Reed Wei After the outbreak, the demand for life biotechnology in the Chinese market will be more and more explosive This will promote China's progress in three aspects: first, the acceleration of original research drugs; second, the demand for intelligent medical treatment under 5g; third, the innovation of high-end life biotechnology Obviously, it is difficult to meet the diversified needs of doctors and patients, give full play to the advantages of resource integration in the industry and even across industries, and provide comprehensive one-stop service for doctors and patients It is also a competitive advantage for pharmaceutical enterprises to improve "voice" and closer to customers in a special period In addition to medical institutions, pharmaceutical enterprises, equipment enterprises, diagnostic equipment reagent companies, third-party testing institutions, online and offline patient service providers, medical big data providers, e-commerce platforms, medical information and content providers will all be important forces in the fight against the epidemic Pharmaceutical enterprises can consider active external cooperation, introduce an open and innovative mode, and Through external platform, information or resources, to fill their own lack of resources and capabilities in serving doctors and patients In terms of sales promotion mode of pharmaceutical enterprises, the digital transformation of pharmaceutical industry has faced great challenges and pressures in policy environment and user acceptance We expect that this epidemic will inject a "boost" into the transformation of digital medicine and digital marketing No matter the government, doctors or patients, they will have a deeper understanding and experience of digital and online platforms, and their acceptance of digital will be improved unprecedentedly At the policy level, Internet hospitals, online prescriptions, Internet pharmacies and online medical insurance are expected to be further liberalized Pharmaceutical enterprises should increase investment in new channels and new innovative sales promotion, continue to optimize the future sales promotion mode, and achieve a more reasonable online and offline sales promotion mode For pharmaceutical commercial enterprises, this epidemic not only tests the response speed of the supply chain, but also tests the ability of overall cooperation, internal immunity, as well as the ability to get rid of the crisis and develop in a balanced way On the one hand, material supply is the responsibility that the pharmaceutical business must bear, on the other hand, the strengthening of brand influence is also a process of accelerating elimination and upgrading The best way to promote the brand is that all sectors of the society are willing to speak for you and contribute heat to the society In the prevention and control of the epidemic, the medical commercial enterprises of the Department go deep into the medical units, and raise and transport emergency materials day and night for several days Through self media, television media, and transportation publicity, there are many touching actions and deeds, which are recognized by the medical units, the government health committee, market supervision, traffic management and other departments I believe that those enterprises that can upgrade themselves and improve their immunity at an extraordinary time will turn crisis into opportunity, gain completely different development and become strong.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.